Circassia Pharmaceuticals (GB:NIOX) has released an update.
Circassia Pharmaceuticals, known as Niox Group PLC, has reported a change in significant shareholdings after Harwood Capital LLP’s voting rights crossed a notable threshold on May 29, 2024. The investment firm now holds a total voting right percentage of 17.8802%, down from their previous position of 18.55% in the pharmaceutical company. This financial move, officially notified on June 5, 2024, reflects a reduction in Harwood’s influence within Niox Group PLC.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
